A p-value of 0.001 is statistically significant by every conventional threshold used in science today. The most common cutoff is 0.05, and 0.001 clears that bar by a wide margin. But calling it “significant” only answers the easiest part of the question. What a p-value of 0.001 actually tells you about the real world, and what it leaves out, is where things get more interesting.
What the Number Means in Plain Terms
A p-value represents the probability of seeing results at least as extreme as the ones you got, assuming there is truly no effect or no difference. A p-value of 0.001 means there is roughly a 1-in-1,000 chance that randomness alone would produce results that dramatic. That sounds compelling, and in many contexts it is. By the widely adopted convention of labeling anything below 0.05 as “statistically significant,” a result of 0.001 is not borderline. It sits comfortably in the zone that researchers, journals, and regulatory agencies treat as evidence that something real is going on.
You will sometimes see results reported with labels like “p < 0.01” or “p < 0.001,” with additional asterisks to flag increasing levels of confidence. These are informal conventions, not formal statistical categories, but they reflect a general intuition: the smaller the p-value, the harder it is to blame the result on chance. A p-value of 0.001 earns the highest tier of asterisks in most reporting systems. So on its face, yes, it is statistically significant, and strongly so.
Why a Very Small P-Value Can Still Be Misleading
Here is where people get tripped up. Statistical significance and practical importance are not the same thing. A p-value tells you whether an effect is likely to be real. It does not tell you whether the effect is large enough to matter. A study might find that a new drug lowers blood pressure by 0.3 mmHg compared to a placebo, with a p-value of 0.001. The result is statistically significant, but a blood-pressure reduction that tiny has no meaningful impact on anyone’s health.
This happens because p-values are heavily influenced by sample size. With enough participants, even a minuscule difference between two groups can produce a very small p-value. A study with tens of thousands of people has so much statistical power that it can detect effects far too small to be clinically relevant, and those effects will come back with impressively low p-values. The result is real in the narrow statistical sense: there genuinely is a difference. But the difference is trivial.
Researchers have a name for this problem. When studies with large samples report extreme statistical significance despite small or trivial effect sizes, and those results are interpreted as practically meaningful without further analysis, it is called the “large sample size fallacy.”1PubMed. The large sample size fallacy A p-value of 0.001 does not indicate a large or important effect. It only indicates that whatever effect was detected is unlikely to be a fluke. Those are two very different statements, and confusing them is one of the most common mistakes in interpreting research.2PubMed Central. Using Effect Size-or Why the P Value Is Not Enough
The reverse is also true. A small study might fail to find a statistically significant result even when a real and clinically important effect exists. If your sample is too small, the study simply does not have the power to detect the effect, so the p-value stays above 0.05 and the result gets labeled “nonsignificant.” That does not mean nothing is happening. It means the study could not see it clearly enough to rule out chance.
What You Should Look at Alongside the P-Value
If the p-value alone is not enough, what else matters? Two things, primarily: effect size and confidence intervals. Effect size tells you how big the difference or relationship actually is. A drug that reduces hospital stays by three days has a much larger effect than one that reduces stays by two hours, even if both produce identical p-values. Confidence intervals tell you the range within which the true effect likely falls, giving you a sense of precision. A study that estimates a treatment effect of 5% with a confidence interval of 3% to 7% is far more informative than one that estimates 5% with a confidence interval of -2% to 12%.
Reporting effect sizes alongside p-values is now considered best practice across much of medical and psychological research. P-values indicate whether an effect exists, but readers need the magnitude of the effect and the precision of the estimate to actually understand what the results mean.2PubMed Central. Using Effect Size-or Why the P Value Is Not Enough When you encounter a study trumpeting a p-value of 0.001, the first follow-up question should always be: how big was the actual effect?
Not Every Field Uses the Same Threshold
The 0.05 cutoff is a convention, not a law of nature, and different fields have adopted very different standards depending on how many comparisons they routinely make and how costly a false positive would be.
Genome-wide association studies are a dramatic example. Researchers scanning the entire human genome for genetic variants associated with a trait or disease are performing millions of statistical tests simultaneously. With that many comparisons, a threshold of 0.05 would produce an overwhelming number of false positives. So the field settled on a much more stringent threshold: 5 × 10⁻⁸, which is 0.00000005.3PubMed Central. Revisiting the genome-wide significance threshold for common variant GWAS In that context, a p-value of 0.001 would not even come close to being considered significant. It would be dismissed as noise.
Particle physics uses a similarly extreme standard, requiring results to reach “five sigma” before claiming a discovery, which corresponds to roughly a 1-in-3.5-million probability of a false alarm. The Higgs boson discovery in 2012, for instance, was not announced until the data cleared that bar. At the other end of the spectrum, some social science and exploratory research treats 0.10 as a threshold worth noting, particularly in pilot studies where the goal is identifying promising leads rather than confirming effects.
The point is that whether 0.001 is “good enough” depends entirely on context. In a clinical trial testing a single primary outcome, 0.001 is strong evidence. In a genomics scan or a high-energy physics experiment, it would barely register.
The Debate Over Lowering the Standard Threshold
The conventional 0.05 threshold has been under fire for years. One prominent proposal suggested that the default for claiming “statistical significance” should be moved from 0.05 to 0.005, which would mean that a p-value of, say, 0.03 would no longer be labeled significant under the new standard. The reasoning: too many published findings that barely cleared the 0.05 bar have failed to replicate, and a stricter threshold would reduce the flood of false positives entering the literature.
A study evaluating what this change would mean in practice looked at previously published randomized clinical trials in three major medical journals and assessed how many results would lose their “significant” label if the threshold were dropped to 0.005.4PubMed Central. Evaluation of Lowering the P Value Threshold for Statistical Significance From .05 to .005 in Previously Published Randomized Clinical Trials in Major Medical Journals The implications are substantial: a meaningful fraction of trials that reported positive results under the 0.05 standard would not meet the stricter criterion, potentially changing clinical recommendations built on those findings.
Under either the current 0.05 threshold or the proposed 0.005 threshold, a p-value of 0.001 passes comfortably. If you are reading a study and wondering whether 0.001 is strong enough to survive a future threshold change, the answer is yes for any reform proposal currently on the table.
P-Hacking and Manufactured Significance
A low p-value is only as trustworthy as the process that produced it. One of the most persistent problems in modern research is “p-hacking,” where researchers collect or select data, tweak their analyses, or choose which outcomes to report until they land on a statistically significant result. Text-mining analyses of the scientific literature have demonstrated that p-hacking is widespread throughout science, not confined to a few bad actors.5PubMed Central. The extent and consequences of p-hacking in science
The manipulations involved can be subtle. A researcher might run the analysis on slightly different subgroups until one produces a significant result. They might exclude certain outliers, or add covariates, or measure several related outcomes and report only the one that worked. Each of these decisions might be defensible in isolation, but stacking them gives the researcher enough flexibility to find significance where none genuinely exists. There is also growing concern about the reverse: selectively reporting nonsignificant results when that serves a researcher’s narrative, or manipulating analyses to push p-values above 0.05 when a null finding is preferred.6PubMed Central. Evidence that nonsignificant results are sometimes preferred: Reverse P-hacking or selective reporting?
What this means for evaluating a p-value of 0.001 is that the number alone is not self-validating. If the study tested dozens of outcomes and only reported the one that hit 0.001, or if the analysis was run multiple ways before settling on the version that produced the best result, that 0.001 is inflated. The real false-positive rate is much higher than the nominal 0.1% the number implies. Context matters: was the study preregistered? Was the analysis plan specified before data collection? Was only one primary outcome tested? These questions are more important than the number of zeros after the decimal point.
Does Preregistration Fix the Problem?
Preregistration, where researchers publicly commit to their hypotheses, methods, and analysis plans before collecting data, is widely promoted as a safeguard against p-hacking. The logic is straightforward: if you cannot rearrange your analysis after seeing the data, you cannot chase a low p-value. And in principle, preregistered studies should produce more conservative effect sizes and fewer suspiciously clean results.
The reality is more complicated. A comparison of preregistered and non-preregistered studies in psychology found that the proportion of positive results was essentially identical between the two groups: about 69% of preregistered studies and 68% of non-preregistered studies reported positive results.7PubMed Central. Preregistration in practice: A comparison of preregistered and non-preregistered studies in psychology Effect sizes were numerically smaller in preregistered studies, but the difference was not statistically significant. Preregistered publications also did not show a lower rate of gross statistical inconsistencies.7PubMed Central. Preregistration in practice: A comparison of preregistered and non-preregistered studies in psychology
This does not mean preregistration is useless. It may be that the practice is still too new and too inconsistently enforced to show its full benefit, or that researchers find ways to deviate from their preregistered plans without consequence. But it does suggest that no single procedural fix turns a p-value into a guarantee. Evaluating any study, including one reporting p = 0.001, still requires looking at the full picture: the design, the sample, the analysis plan, the effect size, and whether the finding replicates.
The Cliff Effect and Threshold Thinking
One of the more subtle problems with p-value thresholds is how they warp people’s interpretation of evidence. Researchers and readers alike tend to treat the significance threshold as a cliff: results on one side are “real” and results on the other side are “nothing.” A study with p = 0.049 gets celebrated; a study with p = 0.051 gets filed away as a failure. In reality, those two results contain almost identical information about the world. The difference between them is trivial, but the perceived difference in what they mean is enormous.
Experimental evidence confirms this pattern. When researchers are given p-values and asked to evaluate the strength of evidence, those working with p-values show more dichotomous, all-or-nothing thinking compared to those given other statistical summaries. The “cliff model,” where evidence strength is perceived to change sharply at a threshold, appears in a substantially higher proportion of researchers interpreting p-values than those using alternative frameworks.8Scientific Reports. Comparing researchers’ degree of dichotomous thinking using frequentist versus Bayesian null hypothesis testing
For a p-value of 0.001, this cliff effect might seem academic. After all, 0.001 is far from any conventional threshold. But the underlying habit of thought still applies. People encountering p = 0.001 tend to treat it as dramatically stronger evidence than, say, p = 0.01, when in practice both are telling you the same basic story: the result is unlikely to be due to chance alone. The tenfold difference in the p-value does not translate to a tenfold difference in how seriously you should take the finding. What matters far more is whether the effect size is meaningful and whether the study was well designed.
When Replication Matters More Than Any Single P-Value
If you take away one thing from the debates around p-values, it should be this: no single study, no matter how impressive its p-value, settles a scientific question. Replication is what builds confidence. A finding that shows up with p = 0.001 in one well-designed study and is then confirmed by independent teams using different samples is far more credible than a one-off result with p = 0.0001 that no one has attempted to replicate.
The replication crisis of the past decade exposed exactly this gap. Many landmark findings in psychology, medicine, and other fields had originally been reported with highly significant p-values but failed to hold up when other labs tried to reproduce them. The original p-values were often technically correct given the data, but the studies had been underpowered, selectively reported, or run on unrepresentative samples. A tiny p-value generated under those conditions is a mirage.
For a non-specialist reading a study, the practical takeaway is relatively simple. If you see p = 0.001, you can be reasonably confident the result is not random noise, assuming the study was conducted honestly and the analysis was not cherry-picked. But “not random noise” is a low bar. You still want to know how big the effect is, whether the study was preregistered, whether anyone has replicated it, and whether the sample was large enough and representative enough to generalize from. A p-value of 0.001 is a starting point for taking a result seriously, not a finishing point for believing it.
Fields Where 0.001 Is Routine and Unremarkable
It is worth noting that in some areas of research, p-values far smaller than 0.001 are produced constantly and treated as table stakes. In genomics, as mentioned, the bar is astronomically higher. In large-scale epidemiological studies analyzing national health databases with millions of records, virtually every variable correlates with every other variable at p < 0.001, simply because the datasets are so enormous. Researchers in these fields have learned the hard way that statistical significance is almost meaningless on its own. What drives decisions is effect size, biological plausibility, and consistency across multiple studies and populations.
In pharmaceutical regulation, the story is different again. The U.S. Food and Drug Administration and equivalent agencies do look at p-values when approving drugs, but they also require two independent confirmatory trials showing the same effect, and they weigh the clinical relevance of the outcome alongside its statistical strength. A drug that produces p = 0.001 for a surrogate endpoint that does not clearly translate to patients feeling better or living longer might still fail to win approval. Statistical significance is necessary but nowhere near sufficient.
Meanwhile, in fields like ecology, education research, or behavioral economics, where sample sizes tend to be smaller and effects are inherently noisier, a p-value of 0.001 is genuinely noteworthy and may represent one of the stronger findings in a given subfield. The same number means different things depending on where you encounter it, which is one more reason that no p-value, however small, should be interpreted in isolation from the study that produced it.